|
Real-time Estimate
Cboe BZX
10:48:28 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 3.915 USD | +8.45% |
|
-2.04% | +10.66% |
| Market Cap | 642M 574M 531M 481M 900M 61.1B 915M 6.39B 2.53B 31.96B 2.41B 2.36B 101B | P/E 2026 * |
-3.65x | P/E 2027 * | -3.83x |
|---|---|---|---|---|---|
| Enterprise Value | 610M 546M 505M 457M 856M 58.06B 870M 6.08B 2.4B 30.37B 2.29B 2.24B 96.16B | EV / Sales 2026 * |
69.1x | EV / Sales 2027 * | 46.8x |
| Free-Float |
79.7% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PRME | Delayed | |
CBOE
| PRME | Real-time |
Last Transcript: Prime Medicine, Inc.
| 1 day | -1.63% | ||
| 1 week | -5.74% | ||
| Current month | +18.17% | ||
| 1 month | +24.48% | ||
| 3 months | +22.37% | ||
| 6 months | -2.43% | ||
| Current year | +4.03% |
| 1 week | 3.38 |  | 4 |
| 1 month | 2.77 | | 4.14 |
| Current year | 2.67 | | 4.82 |
| 1 year | 2.67 | | 5.11 |
| 3 years | 1.11 | | 9.86 |
| 5 years | 1.11 | | 21.73 |
| 10 years | 1.11 | | 21.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Anzalone
PRN | Corporate Officer/Principal | 39 | 2019-09-12 |
Allan Reine
CEO | Chief Executive Officer | 51 | 2025-05-18 |
Svetlana Makhni
DFI | Director of Finance/CFO | 42 | 2026-04-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Nelsen
BRD | Director/Board Member | 62 | 2020-08-31 |
David Schenkein
BRD | Director/Board Member | 68 | 2019-09-12 |
Wendy Chung
BRD | Director/Board Member | 57 | 2021-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/5/26 | Free | Director | 75,000 | 0.0435% | ||
| 4/16/26 | Free | Chief Financial Officer | 800,000 | 0.4638% | ||
| 2/26/26 | Free | Chief Executive Officer | 1,300,000 | 0.7536% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.63% | -5.74% | -32.27% | -39.68% | 642M | |
| +0.88% | -0.34% | +40.64% | +73.05% | 65.28B | |
| -0.51% | -0.51% | +9.23% | +76.57% | 54.57B | |
| -0.63% | +0.86% | +8.95% | +100.38% | 53.59B | |
| -2.06% | +2.90% | +24.07% | +48.36% | 45.03B | |
| -1.79% | +0.19% | +19.32% | +123.62% | 42.17B | |
| -1.65% | +0.96% | +237.56% | +823.66% | 39.42B | |
| -2.26% | -4.14% | +15.38% | +45.53% | 32.71B | |
| -2.70% | -10.77% | +19.80% | -6.47% | 24.01B | |
| +0.02% | +14.34% | +59.09% | +48.23% | 26.5B | |
| Average | -1.23% | +1.57% | +40.18% | +129.32% | 38.39B | |
| Weighted average by Cap. | -0.98% | +2.26% | +45.38% | +147.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.83M 7.9M 7.31M 6.61M 12.38M 840M 12.58M 87.91M 34.78M 439M 33.14M 32.44M 1.39B | 10.55M 9.43M 8.73M 7.9M 14.79M 1B 15.03M 105M 41.55M 525M 39.6M 38.75M 1.66B |
| Net income | -181M -162M -150M -136M -254M -17.24B -258M -1.8B -714M -9.02B -680M -666M -28.55B | -202M -181M -167M -151M -283M -19.22B -288M -2.01B -796M -10.05B -758M -742M -31.83B |
| Net Debt | -31.95M -28.57M -26.44M -23.94M -44.8M -3.04B -45.53M -318M -126M -1.59B -120M -117M -5.03B | -149M -133M -123M -111M -208M -14.15B -212M -1.48B -586M -7.4B -558M -546M -23.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | US$3.840 | +6.37% | 853,605 |
| 26-10-26 | US$3.610 | -1.63% | 2,511,564 |
| 26-10-23 | US$3.670 | -1.61% | 4,562,932 |
| 26-10-22 | US$3.730 | -2.10% | 4,657,700 |
| 26-10-21 | US$3.810 | -2.81% | 2,438,712 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PRME Stock
Select your edition
All financial news and data tailored to specific country editions
